The use of STING antagonists in synergism with PD-1 blockade induced durable anti-tumour immunity with the suppression of peritoneal dissemination of colon cancer and, ultimately, cancer eradication32. This evidence concerns the gene PDCD1 and malignant colon neoplasm.